Abbott Products Operations AG v. Kern Pharma S.L., Court of Appeals (15th Division) of Barcelona, Spain, 15 September 2016, Docket No. 163/2016.

In a Decision rendered on 15 September 2016, the Court of Appeals of Barcelona granted the interim injunctions requested by Abbott against Kern Pharma’s generic Fenofibrate 145 mg. The Court reversed the previous first instance ruling, on the considerations that Kern Pharma’s product preliminary infringes Abbott’s patent EP 1275387.

A summary in English can be read here.
A copy of the decision (in Spanish) can be read here.

Headnote and summary: Luis Fernández-Novoa, HOYNG ROKH MONEGIER